Nurse Practitioner · Houston, TX
NPI
1821486432
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,130
114 services
Medicare patients, 2024
55
Average age 66
Drug cost, 2024
$2.5M
385 prescriptions
Company payments, 2025
$214
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cissimol Joseph was code 99214 (office e&m - established), 45 times for 26 patients. In total Cissimol Joseph billed 114 services in 6 codes, and Medicare paid $8,130.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 45 | 26 | $65.83 | $2,962 |
| 99215 Office E&M - Established | Facility | 18 | 15 | $78.63 | $1,415 |
| 99214 Office E&M - Established | Office | 15 | 11 | $76.44 | $1,147 |
By year: 2022 $3,840 for 59 services; 2023 $4,452 for 61 services; 2024 $8,130 for 114 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cissimol Joseph prescribed most often to Medicare patients was Imatinib Mesylate, with 152 prescriptions and refills. In total Cissimol Joseph wrote 385 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 152 | 162 | 21 | $304K |
| Ondansetron Hcl Generic | 19 | 23 | Under 11 | $1,155 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 17 | 17 | Under 11 | $367 |
| Qinlock Ripretinib | 13 | 13 | Under 11 | $1.1M |
| Gleevec Imatinib Mesylate | 13 | 15 | Under 11 | $147K |
| Pazopanib Hcl Generic | 12 | 12 | Under 11 | $59K |
| Cabometyx Cabozantinib S-Malate | 12 | 12 | Under 11 | $274K |
| Ayvakit Avapritinib | 11 | 11 | Under 11 | $425K |
Brand drugs: 71 claims; generic drugs: 314 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cissimol Joseph $214 ($214 in general payments such as food, travel and fees) from 3 companies. The largest payer was GlaxoSmithKline, LLC. with $119.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.